Ignite Creation Date:
2024-05-06 @ 5:47 PM
Last Modification Date:
2024-10-26 @ 2:35 PM
Study NCT ID:
NCT05424627
Status:
NOT_YET_RECRUITING
Last Update Posted:
2022-06-21
First Post:
2022-06-15
Brief Title:
Myeloid Derived Suppressor Cells in Systemic Lupus Erythematosus
Sponsor:
Organization:
Central Hospital Nancy France
Study Design
Study Type:
OBSERVATIONAL
Expanded Access Type Individual:
None
Expanded Access Type Intermediate:
None
Expanded Access Type Treatment:
None
Patient Registry:
True
Target Duration:
2 Years
Design Allocation:
Design Intervention Model:
Design Intervention Model Description:
Design Masking Description:
Bio Spec Retention:
SAMPLES_WITH_DNA
Bio Spec Description:
Collection of peripheral blood mononuclear cells for functionnal and flow cytometry analysis
Collection of serum for cytokine level assessment
Enrollment Count:
80
Enrollment Type:
ESTIMATED
Design Primary Purpose:
Design Masking:
Phases:
Observational Models:
| Name |
|---|
| Cohort |
Time Perspective List:
Clinical Trial Statuses
| Name |
|---|
| 86661 |
Who Masked List: